No Data
ECHOLIGHT ANNOUNCES MULTI-YEAR AGREEMENT WITH SIEMENS HEALTHINEERS
Siemens Healthineers Full Year 2024 Earnings: EPS Misses Expectations
Siemens Healthineers had a strong performance in the fourth quarter, successfully achieving its goals for the 2024 fiscal year.
Erlangen, Germany, November 6, 2024 / PRNewswire / - Siemens Healthineers today released its financial results for the fourth quarter of the 2024 fiscal year and the fiscal year 2024 ending September 30, 2024. In the 2024 fiscal year - achieving revenue growth and earnings per share (EPS) targets. The equipment order-to-shipment ratio reached an excellent 1.11; backlog orders continued to increase. Despite the complex changes in the Chinese market environment during the 2024 fiscal year, global comparable revenue still grew by 4.7% for the whole year; excluding the COVID-19 antigen rapid testing business discontinued from the previous year, comparable revenue increased by 5.2% on adjusted basis.
SIEMENS HEALTHINEERS AG UNSPON ADR EACH REP 0.50 ORD SHS(SMMNY.US) will release its financial report on November 6th.
$SIEMENS HEALTHINEERS AG UNSPON ADR EACH REP 0.50 ORD SHS(SMMNY.US)$ will release its financial report on November 6th, investors are advised to pay attention. How was the previous performance? $SIEMENS HEALTHINEERS AG UNSPON ADR EACH REP 0.50 ORD SHS(SMMNY.US)$ revenue for 2024/Q3 was 5.423 billion euros, net income was 0.472 billion euros, earnings per share
Patient Testing Set to Be Overhauled With Automation From Siemens Healthineers That Tackles Lab Workflow and Staffing Challenges
For Patients at Risk, a Simple Blood Test Can Help Doctors Predict Likelihood of Future Heart Attack, Other Cardiac Events, and Death
No Data
No Data